Ledipasvir相关论文
由直接作用抗病毒药物来地帕韦(NSSA蛋白抑制剂)和索他洛尔(NSSB聚合酶抑制剂)组成的复方片剂是第一个被批准用于临床的丙肝抗病毒......
为探究吕家坨井田地质构造格局,根据钻孔勘探资料,采用分形理论和趋势面分析方法,研究了井田7......
以1-(7-溴-9,9-二氟-9H-芴-2-基)-2-氯乙酮和(6S)-5-氮杂螺[2.4]庚烷-5,6-二甲酸5-叔丁酯钾盐为原料,通过优化其工艺条件,开发了一......
Second-generation direct-acting-antiviral hepatitis C virus treatment: Efficacy, safety, and predict
AIM To gather data on the antiviral efficacy and safety of second generation direct acting antiviral(DAA) treatment with......
Hepatitis C virus genotype 3: Meta-analysis on sustained virologic response rates with currently ava
AIM: To address the therapeutic efficacy of various treatment regimens in genotype 3 selecting randomized clinical trial......
Impact of interferon-free antivirus therapy on lipid profiles in patients with chronic hepatitis C g
AIM To investigate the influence of interferon-free antivirus therapy on lipid profiles in chronic hepatitis C virus gen......
Miliary tuberculosis infection during hepatitis C treatment with sofosbuvir and ledipasvir plus riba
Chronic hepatitis C virus(HCV) infection is one of the main causes of chronic liver disease worldwide. In the last 5 yea......
Chronic hepatitis C infection is the leading cause ofchronic liver disease, cirrhosis, hepatocellular carcinomaas well a......
Hepatitis C virus(HCV)has infected more than 200 million people around the globe.From 2001-2011,interferon plus ribaviri......
